Dicerna Pharma (DRNA) Misses Q2 EPS by 55c
Dicerna Pharma (NASDAQ: DRNA) reported Q2 EPS of ($1.15), $0.55 worse than the analyst estimate of ($0.60).
For earnings history and earnings-related data on Dicerna Pharma (DRNA) click here.
Dicerna Pharma (NASDAQ: DRNA) reported Q2 EPS of ($1.15), $0.55 worse than the analyst estimate of ($0.60).
For earnings history and earnings-related data on Dicerna Pharma (DRNA) click here.